Insiders · Profile

Lim Bryant David

CLO, Interim CFO, Corp Sec. at Prelude Therapeutics. Filing since 24 May 2023. CIK 0001752888

Company

Date

Role

Action

Amount

Of holding

19 Dec 2024

CLO, Interim CFO, Corp Sec.

Bought

25,000

$22.64K

×10

24 May 2023

Chief Legal Officer, Corp Sec.

Bought

2,400

$12.94K

opened

2 decisions on file.